Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells

Stem Cells and Development

Volumn 24, Issue 3, 2015, Pages 345-353

  Wang, Ji ^a   Huang, Vera ^a   Ye, Lin ^b   Bárcena, Alicia ^a   Lin, Guiting ^a   Lue, Tom F ^a   Li, Long Cheng ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE PROTEIN; DNA; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RNA; SMALL ACTIVATING RNA; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VALPROIC ACID; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; KRUPPEL LIKE FACTOR; MYC PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; SMALL UNTRANSLATED RNA; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADIPOSE DERIVED STEM CELL; ARTICLE; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROMOTER REGION; RNA ACTIVATION; RNA ANALYSIS; SCREENING; TRANSCRIPTION INITIATION; UPREGULATION; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; INDUCED PLURIPOTENT STEM CELL; ISOLATION AND PURIFICATION; MESENCHYMAL STROMA CELL; METABOLISM; ONCOGENE MYC; PHARMACOLOGY; PHYSIOLOGY;

IPS;

EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENES, MYC; GENETIC VECTORS; HISTONE DEACETYLASE INHIBITORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESENCHYMAL STROMAL CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS; RNA, SMALL UNTRANSLATED; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VALPROIC ACID;

EID: 84921491581     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0290     Document Type: Article

References (38)

1. Turner MJ, AL Jiao and FJ Slack. (2014). Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans. Cell Cycle 13:772-781.
2. Seth M, M Shirayama, W Gu, T Ishidate, D Conte Jr., and CC Mello. (2013). The C. elegans CSR-1 argonaute pathway counteracts epigenetic silencing to promote germline gene expression. Dev Cell 27:656-663.
3. Li LC, ST Okino, H Zhao, D Pookot, RF Place, S Urakami, H Enokida and R Dahiya. (2006). Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 103:17337-17342.
4. Janowski BA, ST Younger, DB Hardy, R Ram, KE Huffman and DR Corey. (2007). Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 3:166-173.
5. Huang V, Y Qin, J Wang, X Wang, RF Place, G Lin, TF Lue and LC Li. (2010). RNAa is conserved in mammalian cells. PLoS One 5:e8848.
6. Huang V, RF Place, V Portnoy, J Wang, Z Qi, Z Jia, A Yu, M Shuman, J Yu and LC Li. (2012). Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res 40:1695-1707.
7. Place RF, LC Li, D Pookot, EJ Noonan and R Dahiya. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105:1608-1613.
8. Dharap A, C Pokrzywa, S Murali, G Pandi and R Vemuganti. (2013). MicroRNA miR-324-3p induces promotermediated expression of RelA gene. PLoS One 8:e79467.
9. Place RF, J Wang, EJ Noonan, R Meyers, M Manoharan, K Charisse, R Duncan, V Huang, X Wang and LC Li. (2012). Formulation of small activating RNA into lipidoid nanoparticles inhibits xenograft prostate tumor growth by inducing p21 expression. Mol Ther Nucleic Acids 1:e15.
10. Ren S, MR Kang, J Wang, V Huang, RF Place, Y Sun and LC Li. (2013). Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate 73:1591-1601.
11. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
12. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
13. Hou P, Y Li, X Zhang, C Liu, J Guan, H Li, T Zhao, J Ye, W Yang, et al. (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651-654.
14. Warren L, PD Manos, T Ahfeldt, YH Loh, H Li, F Lau, W Ebina, PK Mandal, ZD Smith, et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-630.
15. Miyoshi N, H Ishii, H Nagano, N Haraguchi, DL Dewi, Y Kano, S Nishikawa, M Tanemura, K Mimori, et al. (2011). Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8:633-638.
16. Zhou H, S Wu, JY Joo, S Zhu, DW Han, T Lin, S Trauger, G Bien, S Yao, et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381-384.
17. Wang X, J Wang, V Huang, RF Place and LC Li. (2012). Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J 443:821-828.
18. Kim JB, V Sebastiano, G Wu, MJ Arauzo-Bravo, P Sasse, L Gentile, K Ko, D Ruau,MEhrich, et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell 136:411-419.
19. Tsai SY, BA Bouwman, YS Ang, SJ Kim, DF Lee, IR Lemischka and M Rendl. (2011). Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells 29:964-971.
20. Pardo M, B Lang, L Yu, H Prosser, A Bradley, MM Babu and J Choudhary. (2010). An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 6:382-395.
21. Wang X and J Dai. (2010). Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells 28:885-893.
22. Hawkins PG and KV Morris. (2010). Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcription 1:165-175.
23. Li W, E Tian, ZX Chen, G Sun, P Ye, S Yang, D Lu, J Xie, TV Ho, et al. (2012). Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc Natl Acad Sci U S A 109:20853-20858.
24. Ning H, G Liu, G Lin, M Garcia, LC Li, TF Lue and CS Lin. (2009). Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation 77:172-180.
25. Ye L, JC Chang, C Lin, X Sun, J Yu and YW Kan. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A 106:9826-9830.
26. Liedtke S, J Enczmann, S Waclawczyk, P Wernet and G Kogler. (2007). Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 1:364-366.
27. Sun N, NJ Panetta, DM Gupta, KD Wilson, A Lee, F Jia, S Hu, AM Cherry, RC Robbins, MT Longaker and JC Wu. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 106:15720-15725.
28. Portnoy V, V Huang, RF Place and LC Li. (2011). Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA 2:748-760.
29. Huangfu D, K Osafune, R Maehr, W Guo, A Eijkelenboom, S Chen, W Muhlestein and DA Melton. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269-1275.
30. Zhu S, W Li, H Zhou, W Wei, R Ambasudhan, T Lin, J Kim, K Zhang and S Ding. (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7:651-655.
31. Li LC. (2014). Chromatin remodeling by the small RNA machinery in mammalian cells. Epigenetics 9:45-52.
32. Schwartz JC, ST Younger, NB Nguyen, DB Hardy, BP Monia, DR Corey and BA Janowski. (2008). Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol 15:842-848.
33. Voutila J, P Saetrom, P Mintz, G Sun, J Alluin, JJ Rossi, NA Habib and N Kasahara. (2012). Gene expression profile changes after short-activating RNA-mediated induction of endogenous pluripotency factors in human mesenchymal stem cells. Mol Ther Nucleic Acids 1:e35.
34. Marti M, L Mulero, C Pardo, C Morera, M Carrio, L Laricchia-Robbio, CR Esteban and JC Izpisua Belmonte. (2013). Characterization of pluripotent stem cells. Nat Protoc 8:223-253.
35. Yu J, KF Chau, MA Vodyanik, J Jiang and Y Jiang. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS One 6:e17557.
36. Wang H, N Cao, CI Spencer, B Nie, T Ma, T Xu, Y Zhang, X Wang, D Srivastava and S Ding. (2014). Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Rep 6:951-960.
37. Szabo E, S Rampalli, RM Risueno, A Schnerch, R Mitchell, A Fiebig-Comyn, M Levadoux-Martin and M Bhatia. (2010). Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468:521-526.
38. Zhu S, R Ambasudhan, W Sun, HJ Kim, M Talantova, X Wang, M Zhang, Y Zhang, T Laurent, et al. (2014). Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. Cell Res 24:126-129.